UK_Decision_EN_FinalPR


News Release Your Contact

Neetha Mahadevan +49 6151 72-6328


January 15, 2016


Merck Announces Favorable English Court Ruling on Name Use


  • Court says MSD breached an agreement with Merck by using "Merck" alone either as a trade mark or a name in the UK


Darmstadt, Germany, January 15, 2016 - Merck, a leading science and technology company, today announced it secured a favorable ruling in the English Court following almost three years of litigation with US-based Merck Sharp & Dohme Corp (MSD) regarding the use of the term "Merck".


In its judgement the English High Court stated that MSD had breached an agreement with the company by using "Merck" alone in the UK either as a trade mark or a name, online or offline. Merck and MSD had entered the agreement in 1955 and amended it in 1970. According to this agreement, Merck is entitled to use the name everywhere in the world, except the U.S. and Canada.


"Our objective has been to protect the status quo established in the existing agreement", said Friederike Rotsch, General Counsel at Merck. "Therefore, we are pleased that the English court has upheld our argument that MSD's use of our name and brand 'MERCK' in our territories is beyond the limits agreed with MSD."


Merck relaunched its brand identity last year to reflect the transformation into a global science and technology company with three strong businesses in Healthcare Life Science and Performance Material and create a distinct identity vis-à-vis its patients, customers and investors across various industries and geographies.


Page 1 of 2


Frankfurter Strasse 250 64293 Darmstadt · Germany Hotline +49 6151 72-5000

merckgroup.com

Head Media Relations -62445 Spokesperson: -9591 / -7144 / -6328

Fax +49 6151 72 3138

media.relations@merckgroup.com

News Release


The judge said Merck was entitled to an order to prevent MSD from describing itself in any printed or digital material addressed to the UK as "'Merck" alone, and restraining MSD's use of the trade mark "MERCK" alone. The judge also held that MSD's use of "Merck" as part of branding on its global websites were directed to the UK and infringed Merck's trade mark rights in the UK.


All Merck Press Releases are distributed by e-mail at the same time they become available on the Merck Website. Please go to www.merckgroup.com/subscribe to register online, change your selection or discontinue this service.


About Merck

Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life - from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2014, Merck generated sales of € 11.3 billion in 66 countries.

Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.


Page 2 of 2

Merck KGaA issued this content on 2016-01-15 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 2016-01-15 17:26:04 UTC

Original Document: http://news.merck.de/N/0/9D112F8F7BF34BDDC1257F3B004413E7/$File/UK_Decision_EN_FinalPR.pdf